Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cardiff Oncology Inc (CRDF)

Cardiff Oncology Inc (CRDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 129,369
  • Shares Outstanding, K 51,134
  • Annual Sales, $ 490 K
  • Annual Income, $ -41,440 K
  • EBIT $ -46 M
  • EBITDA $ -47 M
  • 60-Month Beta 1.93
  • Price/Sales 274.53
  • Price/Cash Flow N/A
  • Price/Book 2.43

Options Overview Details

View History
  • Implied Volatility 241.89% ( -3.53%)
  • Historical Volatility 118.21%
  • IV Percentile 86%
  • IV Rank 35.53%
  • IV High 628.39% on 09/18/24
  • IV Low 28.90% on 05/22/24
  • Put/Call Vol Ratio 1.55
  • Today's Volume 321
  • Volume Avg (30-Day) 2,261
  • Put/Call OI Ratio 0.57
  • Today's Open Interest 33,237
  • Open Int (30-Day) 21,136

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.25
  • Number of Estimates 4
  • High Estimate -0.23
  • Low Estimate -0.29
  • Prior Year -0.21
  • Growth Rate Est. (year over year) -19.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.51 +1.00%
on 11/20/24
4.38 -42.24%
on 11/07/24
-0.37 (-12.76%)
since 10/18/24
3-Month
2.09 +21.05%
on 09/06/24
4.38 -42.24%
on 11/07/24
+0.23 (+10.00%)
since 08/20/24
52-Week
1.12 +125.89%
on 11/21/23
6.42 -60.59%
on 03/25/24
+1.37 (+118.10%)
since 11/20/23

Most Recent Stories

More News
Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRC

CRDF : 2.53 (-3.44%)
Cardiff Oncology: Q3 Earnings Snapshot

Cardiff Oncology: Q3 Earnings Snapshot

CRDF : 2.53 (-3.44%)
Cardiff Oncology Reports Third Quarter 2024 Results and Provides Business Update

CRDF : 2.53 (-3.44%)
Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data from Phase 2 Trial in Second-line KRAS Mutant mCRC

CRDF : 2.53 (-3.44%)
Cardiff Oncology: Q2 Earnings Snapshot

Cardiff Oncology: Q2 Earnings Snapshot

CRDF : 2.53 (-3.44%)
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:ZLAB),(NASDAQ:NTBL),(NASDAQ:CRDF),(NYSE:JNJ) EQNX::TICKER_END

ONCY : 0.9985 (-5.80%)
ONC.TO : 1.40 (-5.41%)
ZLAB : 26.23 (+0.31%)
NTBL : 0.2479 (-27.68%)
CRDF : 2.53 (-3.44%)
JNJ : 153.11 (+0.07%)
Rising Number of Studies to Develop Novel Therapies For Pancreatic Ductal Adenocarcinoma (PDAC) Intensely Increasing

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:CRDF),(NYSE:LLY),(NYSE:ABBV),(NASDAQ:LIPO) EQNX::TICKER_END

ONCY : 0.9985 (-5.80%)
ONC.TO : 1.40 (-5.41%)
CRDF : 2.53 (-3.44%)
LLY : 753.41 (+3.25%)
ABBV : 167.76 (+0.71%)
LIPO : 2.41 (-3.21%)
Nasdaq Futures Climb as Bond Yields Retreat From Decade Highs, Micron Earnings on Tap

December Nasdaq 100 E-Mini futures (NQZ23) are trending up +0.44% this morning as U.S. Treasury yields slipped from decade highs, while investors braced for a new round of economic data as well as an earnings...

NQZ23 : 16,530.23s (-0.07%)
CTAS : 218.75 (+0.36%)
AAPL : 229.00 (+0.32%)
GOOGL : 175.98 (-1.20%)
AMZN : 202.88 (-0.85%)
DKNG : 43.80 (+1.37%)
MU : 98.37 (+0.65%)
PAYX : 141.83 (+0.83%)
JEF : 74.91 (+0.39%)
HMB.S.DX : 152.250 (-0.57%)
COST : 928.08 (-0.22%)
CHPT : 1.0900 (-3.54%)
Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy

Pancreatic Cancer Program - Pancreatic cancer Phase 2 trial of onvansertib + SoC in the second-line setting demonstrated greater efficacy vs. historical...

CRDF : 2.53 (-3.44%)
Cardiff Oncology to Present at Upcoming Investor Conferences in September

/PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug...

CRDF : 2.53 (-3.44%)

Business Summary

Cardiff Oncology Inc. is a clinical-stage biotechnology company. It engages in developing treatment for cancer patients. The company's product pipeline consists of a Phase 1b/2 study of onvansertib in combination with FOLFIRI/Avastin(R) in KRAS-mutated metastatic colorectal cancer; a Phase 2 study of...

See More

Key Turning Points

3rd Resistance Point 2.77
2nd Resistance Point 2.71
1st Resistance Point 2.62
Last Price 2.53
1st Support Level 2.47
2nd Support Level 2.41
3rd Support Level 2.32

See More

52-Week High 6.42
Fibonacci 61.8% 4.40
Fibonacci 50% 3.77
Fibonacci 38.2% 3.14
Last Price 2.53
52-Week Low 1.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar